Treatment of fallopian tube cancer: Review of the literature

Archives of Gynecology and Obstetrics

Volumn 264, Issue 1, 2000, Pages 13-19

  Takeshima, N ^a   Hasumi, K ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Chemotherapy; Fallopian tube cancer; Lymph node metastasis; Prognosis; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; HORMONE RECEPTOR; IFOSFAMIDE; PACLITAXEL; PLATINUM DERIVATIVE; PROGESTERONE RECEPTOR; RADIOISOTOPE;

CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HORMONAL THERAPY; HUMAN; INTERMETHOD COMPARISON; LAPAROTOMY; LYMPH NODE METASTASIS; PELVIS LYMPH NODE; PROGNOSIS; RADIOISOTOPE THERAPY; REVIEW; SECOND LOOK SURGERY; TREATMENT OUTCOME; UTERINE TUBE TUMOR;

EID: 0033800428     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00007475     Document Type: Review

References (55)

1. Primary adenocarcinoma localized to the fallopian tubes: Report on 33 cases
2. Second-look laparotomy in carcinoma of the fallopian tube
3. Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube
4. Adenocarcinoma of the fallopian tube - Experience with 41 patients
5. Chemotherapy for disseminated tubal cancer
6. Primary carcinoma of the fallopian tube. A retrospective analysis of 47 patients
7. Second-look laparotomy in the management of fallopian tube carcinoma
8. Treatment of fallopian tube carcinoma with cyclophosphamide, adriamycin, and cisplatin
9. Revision in classification by International Federation of Gynecology and Obstetrics
10. The management of primary carcinoma of the fallopian tube - Experience of 40 cases
11. Fallopian tube cancer: Incidence and role of lymphatic spread
12. Clinical aspects of fallopian tube carcinoma
13. Second-look laparotomy in fallopian tube carcinoma
14. Fallopian tube carcinoma
15. Das primare Tubenkarzinom - Eine klinische Studie an 37 Patientinnen
16. Primary carcinoma of the fallopian tube
17. The management of primary fallopian tube carcinoma
18. Primary carcinoma of the fallopian tube
19. Carcinoma of the fallopian tube: Clinical management
20. Analysis of 23 cases of primary carcinoma of the fallopian tube over 50 years
21. Treatment of carcinoma of the fallopian tube using cisplatin, doxorubicin, and cyclophosphamide
22. Primary fallopian tube carcinoma - A retrospective survey of 51 cases
23. Lymphogenous metastasis in the primary carcinoma of the fallopian tube
24. Evaluation of adjuvant therapy after surgery for primary carcinoma of the fallopian tube
25. Whole abdominal external beam radiation in the treatment of primary carcinoma of the fallopian tube
26. Primary carcinoma of the fallopian tube: Evidence for activity of cisplatin combination therapy
27. Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms
28. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
29. Carcinoma of the fallopian tube. Management and sites of failure
30. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide
31. Combination chemotherapy in advanced adenocarcinoma of the fallopian tube
32. Primary carcinoma of the fallopian tube: Report on two cases
33. Treatment of primary fallopian tube carcinoma with cisplatin-containing chemotherapy
34. Prognostic features of carcinoma of the fallopian tube
35. Results of chemotherapy in advanced carcinoma of the fallopian tube
36. Primary carcinoma of the fallopian tube
37. Primary carcinoma of the fallopian tube. Report of 22 cases
38. Primary adenocarcinoma of the fallopian tube
39. Fallopian tube cancer. The Roswell Park experience
40. Primary carcinoma of the fallopian tube - A retrospective analysis of 115 patients
41. Preoperative and postoperative CA-125 serum levels in primary fallopian tube carcinoma
42. Prognostic factors in primary fallopian tube carcinoma
43. A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer
44. Prognostic factors for recurrence following negative second-look laparatomy in ovarian cancer patients treated with platinum-based chemotherapy
45. Ten-year follow-up of ovarian cancer patients after second look laparotomy with negative findings
46. Fallopian tube cancer: The role of radiation therapy
47. Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival
48. Fallopian tube adenocarcinoma: Common extraperitoneal recurrence
49. Neoadjuvant chemotherapy for advanced ovarian cancer
50. Clinical usefulness of endometrial aspiration cytology and CA-125 in the detection of fallopian tube carcinoma
51. Adenocarcinoma of the uterine tube. Potential for lymph node metastases
52. Serial measurement of CA125 in patients with primary carcinoma of the fallopian tube
53. Primary fallopian tube adenocarcinoma: Clinical complete response after salvage treatment with high-dose paclitaxel
54. Carcinoma of the fallopian tube